about
Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standardHigh burden of non-influenza viruses in influenza-like illness in the early weeks of H1N1v epidemic in France.I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275YEpisodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.High prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assaysDiagnosis of genital herpes simplex virus infection in the clinical laboratoryImpact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South AfricaLong-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.Comparison of washing and swabbing procedures for collecting genital fluids to assess cervicovaginal shedding of herpes simplex virus type 2 DNA.HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in TanzaniaAffinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples.Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.Evaluation of a New Device for Simplifying and Standardizing Stool Sample Preparation for Viral Molecular Testing with Limited Hands-On TimeVariability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.HHV-6 reactivation as a cause of fever in autologous hematopoietic stem cell transplant recipients.The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.Molecular characterization of the 17D-204 yellow fever vaccine.Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia.First next-generation sequencing full-genome characterization of a hepatitis C virus genotype 7 divergent subtype.Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014.Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.First HSV-1 non primary genital herpes in two patients.Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment.Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.Human metapneumovirus pneumonia in patients with hematological malignancies.Acute enteritis associated with Coxsackievirus A19 in a kidney transplant patient.Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.Burden of respiratory viruses in patients with acute respiratory failure.Evaluation of the one-step multiplex real-time reverse transcription-PCR ProFlu-1 assay for detection of influenza A and influenza B viruses and respiratory syncytial viruses in children.Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.Cell-associated, non-replicating strand(+) hepatitis C virus-RNA shedding in cervicovaginal secretions from chronically HCV-infected women.Erratum to: Diagnosis of genital herpes simplex virus infection in the clinical laboratory.Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors.
P50
Q28680756-7442B04E-870E-4FEA-AE52-D3EF55DE46B4Q30406249-1DD7BBA0-C557-4C7A-A739-12A171E4296AQ30420810-38C60E47-9BAF-4039-BEB4-3F5FE0FEF6B9Q31028568-AF3C5879-6A69-44A4-A798-56EAE83DC794Q33592272-A2BCE763-713B-42D9-B8B2-371AA5698C44Q33655295-D2225C91-FBEA-46B8-A783-4BDF90DCE181Q34168214-59144EDC-DC11-45C3-99F5-604CDCF647DAQ34168234-B2A9B246-F3C4-432A-94A4-C510CC5A48C9Q34994204-EF03AD8C-BC95-459D-9295-4E7CE4953EAAQ34995949-BB2D7744-27D4-4609-94F5-0BB475DCD36FQ35026748-100CB586-44E1-4E03-B61F-FE97FE39F852Q35585672-D66C0267-EB0F-4E6E-A95B-522BE8F5A45AQ35740472-25BA757D-416B-4CB6-B597-09666AEA9D4BQ37027756-07447EBF-110D-48BC-BC6C-AB115304451AQ37546751-2767E527-1CD5-4A02-9915-D0020ED44509Q38380804-3DD89DDB-297F-49A4-94B0-2332375A5BE5Q38382681-2C686539-C7B1-4FDF-9DC7-0BD5CADB7094Q39168808-2625490F-8379-4817-831A-BD58822BFAC8Q40055227-561B2229-33EC-4EA4-8B07-2C3974D9DE31Q40101455-43DDFB82-ED44-4238-8820-7F41087FD05CQ40141454-22CFCD7C-479B-4913-B5A7-6966CC46D202Q40141583-95CDA814-6946-4D02-B6AB-A47B69D1658EQ40175494-42E47078-8BE1-456C-B7F4-AEA0454FE2DDQ40578886-8B0428A2-1EF5-4C44-92EB-457FC836C551Q40668086-E4A903A5-5011-4063-9621-E056BD250F68Q40696289-23B867C2-03F8-4EE9-9589-92C20A3955BFQ40739369-CE3D5B69-7E83-405C-ADED-F11039B078F6Q40886857-0E626D12-6DDB-4353-8BA8-9FD169F5B410Q41326005-99F04833-E443-4A36-AE67-49D86832766AQ41432144-8740EE9C-3CAE-42BF-BAFD-E5C6DF0E5DD3Q41640118-87F764FA-0923-4042-855B-00F0E9BB1F3FQ42224060-17A1ABAA-60C7-4BAB-B412-0CCB434A6E0EQ42248755-53D14A9D-76A1-4E00-B90D-4074AA8C056AQ42263761-B193F85F-BCCD-4A40-A8B9-5D75CB90D871Q42266464-F357D41F-2491-4326-8BD9-7DA5267A7EDCQ42267196-CCB50A6E-413B-4C56-AEC3-B32FA6C2D271Q42860985-3E777F7D-65E4-46B9-8E66-A8507DD1A160Q43047558-F8D0F84A-2D59-468D-9621-23A08D273193Q43221914-AF330FF0-9270-470D-A782-D6CAF758DF27Q44124733-4A0F91F5-3997-4EE8-B642-C8E660DEFDAC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jerome LeGoff
@ast
Jerome LeGoff
@en
Jerome LeGoff
@es
Jerome LeGoff
@nl
Jerome LeGoff
@sl
type
label
Jerome LeGoff
@ast
Jerome LeGoff
@en
Jerome LeGoff
@es
Jerome LeGoff
@nl
Jerome LeGoff
@sl
altLabel
goff jl
@en
le goff j
@en
prefLabel
Jerome LeGoff
@ast
Jerome LeGoff
@en
Jerome LeGoff
@es
Jerome LeGoff
@nl
Jerome LeGoff
@sl
P106
P21
P31
P496
0000-0001-7111-1865